About this trial
The Continence, Sexual and Metabolic Health (CONTROL 4 LIFE) study will evaluate the recovery of continence, sexual function, and health outcomes in individuals who have undergone surgery for prostate cancer. The purpose of this study is to better understand the timelines of recovery for these outcomes after surgery for prostate cancer. As part of this study, all participants will receive resources offered by Alberta Health Services regarding pre- and post-prostatectomy care, including information on pelvic floor exercises. Through the CONTROL 4 LIFE study, the investigators will also be evaluating outcomes related to physical activity, fitness and quality of life. These assessments will enable the investigators to better understand how well and how long it takes for individuals to recover after surgery for prostate cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
have a diagnosis of prostate cancer (stage I to IV);
be scheduled for a prostatectomy surgery (any surgical approach);
have no restriction to participate in at least mild levels of physical activity, as confirmed by the Physical Activity Readiness Questionnaire (PAR-Q+);
speak and understand English.
Disqualifiers
have any medical conditions that may interfere with continence (i.e. neurological diseases);
have any contraindications to exercise testing or training;
have recent (>6 months) modifications to any medication aiming to reduce urinary incontinence (i.e. Myrbetric);
do not have regular access to the internet and a smart device or a computer at home/ at their community center;
Trial design
Parallel
Treatments tested in this trial
Pelvic floor exercise program
BehavioralGeneral exercises will be prescribed along with a specialized pelvic floor program
General exercise
BehavioralA general progressive resistance exercise program
Physical Activity Counseling
BehavioralAdvice on increasing physical activity
Treatment groups
Trial outcomes
Primary outcomes
Completion Rate
The number of participants completing the study including all planned outcomes
Secondary outcomes
Recruitment rate
Percentage of participants who are eligible and agree to participate
Adherence rate
Adherence to the intervention components
24-hour pad test
Mean: Individual's urine loss by measuring weight (grams) of an absorbent pad
Expanded Prostate Cancer Index Composite for Clinical Practice
16-questions: urinary function, sexual and erectile function, bowel and hormonal function; Scores: 0 (no symptoms) to 60 (most severe symptoms); Higher scores indicate worse functioning
Sponsors and contacts
Click on the lead sponsor to view all of their trials.